Fairview Health Services
Fairview Health Services was paid $9.36M by Medicaid between Jan 2018 and Nov 2024, across 56 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
PRINCETON, MN 55371
Next to other Clinical Pathology/Laboratory Medicine Physician providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,986 | $624K | |
| 2019 | 13,807 | $1.31M | |
| 2020 | 8,028 | $818K | |
| 2021 | 15,823 | $1.52M | |
| 2022 | 18,573 | $1.81M | |
| 2023 | 21,168 | $2.03M | |
| 2024incomplete | 11,568 | $1.25M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 17,218 | 16,000 | $2.76M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 13,015 | 11,875 | $2.59M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 28% | 10,201 | 9,184 | $2.59M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.3% | 3,396 | 3,105 | $312K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.5% | 1,813 | 664 | $231K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 2,300 | 2,068 | $156K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.6% | 1,233 | 1,205 | $151K |
| 80053 | Comprehensive metabolic panel | 1.4% | 7,635 | 7,033 | $136K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,635 | 1,479 | $84K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 510 | 494 | $63K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,940 | 8,251 | $51K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 518 | 500 | $37K |
44 more codes
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,914 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,366 | $29K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,032 | $18K |
| 71045 | Radiologic examination, chest; single view | <1% | 349 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 257 | $18K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 24 | $16K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 111 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 461 | $9K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 383 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 221 | $6K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 208 | $5K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 40 | $5K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 90 | $4K |
| 87081 | <1% | 289 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 12 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,841 | $3K |
| 81001 | <1% | 3,086 | $2K | |
| 86140 | <1% | 752 | $2K | |
| 83690 | <1% | 534 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 12 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 105 | $1K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,582 | $1K |
| 84484 | <1% | 137 | $820.34 | |
| J2704 | Injection, propofol, 10 mg | <1% | 891 | $790.43 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 27 | $778.80 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 543 | $545.51 |
| 83605 | <1% | 51 | $461.77 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 87 | $456.25 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 94 | $367.34 |
| 85610 | <1% | 89 | $341.28 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 840 | $315.56 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 504 | $256.71 |
| 83880 | <1% | 16 | $242.73 | |
| 96376 | <1% | 13 | $233.51 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 229 | $215.20 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $189.61 |
| 83735 | <1% | 43 | $171.50 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 315 | $95.60 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 110 | $33.31 |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 12 | $15.40 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $2.85 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 716 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 116 | $0.00 |
| 81025 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
| Fairview Clinics | Princeton, MN | $4.05M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.